13F Data
13F filer · CIK 1744967

SAMSARA BIOCAPITAL, LLC

PALO ALTO, CA · filing since Q4 2018 · last filing Aug 14, 2026
Reported value
$1.2B
+$188.4M vs prior
Positions
24
New / sold out
4 / 2
Added / reduced
2 / 5
Turnover
2.0%
buys $102.9M · sells $22.1M
Top-10 weight
90.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewALAMAR BIOSCIENCES INC+2,480,310–+$67.2M
NewPARABILIS MEDICINES INC+556,044–+$15.2M
NewARTIVA BIOTHERAPEUTICS INC+954,861–+$9.3M
NewELOXX PHARMACEUTICALS INC+400,000–+$5.6M
AddedINVENTIVA SA+1,120,000+21.6%+$4.2M
AddedRANI THERAPEUTICS HLDGS INC+1,869,159+22.0%+$1.4M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outARCELLX INC-60,873-100.0%$-7.0M
ReducedJADE BIOSCIENCES INC-232,561-24.0%$-5.2M
Sold outPALVELLA THERAPEUTICS INC NE-38,432-100.0%$-4.8M
ReducedUPSTREAM BIO INC-382,330-51.9%$-2.6M
ReducedX4 PHARMACEUTICALS INC-436,979-23.8%$-2.0M
ReducedKALARIS THERAPEUTICS INC-66,906-0.5%$-272.3K
ReducedABIVAX SA-1,486-2.6%$-198.0K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2018: $104.2MQ1 2019: $127.2MQ2 2019: $151.4MQ3 2019: $146.9MQ4 2019: $208.7MQ1 2020: $173.8MQ2 2020: $310.9MQ3 2020: $358.5MQ4 2020: $487.4MQ1 2021: $542.2MQ2 2021: $810.1MQ3 2021: $637.3MQ4 2021: $515.5MQ1 2022: $397.2MQ2 2022: $375.1MQ3 2022: $428.9MQ4 2022: $464.6MQ1 2023: $483.8MQ2 2023: $569.7MQ3 2023: $326.7MQ4 2023: $642.8MQ1 2024: $646.4MQ2 2024: $477.8MQ3 2024: $520.3MQ4 2024: $728.6MQ1 2025: $560.8MQ2 2025: $488.9MQ3 2025: $765.9MQ4 2025: $969.3MQ1 2026: $1.0BQ2 2026: $1.2B
Q4 2018Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1SCHOLAR ROCK HLDG CORPCOM6,897,652$379.4M31.16%
2ALUMIS INCCOM6,345,219$178.6M14.67%
3MINERALYS THERAPEUTICS INCCOM5,871,018$158.4M13.01%
4SEPTERNA INCCOM3,149,128$105.5M8.66%
5ALAMAR BIOSCIENCES INCCOMMON STOCK2,480,310$67.2M5.52%
6NEUROGENE INCCOM1,717,127$54.0M4.44%
7KALARIS THERAPEUTICS INCCOM12,881,175$52.4M4.31%
8SPYGLASS PHARMA INCCOM SHS2,109,953$47.0M3.86%
9SUTRO BIOPHARMA INCCOM SHS1,062,872$35.3M2.90%
10INVENTIVA SAADS6,314,805$23.9M1.96%
14 more rows. Subscribe for $29/month to see every row, download the data and use the API.